Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. [electronic resource]
Producer: 20090421Description: 606-12 p. digitalISSN:- 1097-6744
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Arthritis -- drug therapy
- Cardiovascular Diseases -- epidemiology
- Celecoxib
- Cyclooxygenase Inhibitors -- administration & dosage
- Dose-Response Relationship, Drug
- Double-Blind Method
- Follow-Up Studies
- Humans
- Ibuprofen -- administration & dosage
- Middle Aged
- Naproxen -- administration & dosage
- Prospective Studies
- Pyrazoles -- administration & dosage
- Sulfonamides -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.